Literature DB >> 34117079

To Add Weight to Overweight.

Maatje D A van Gastel1, Esther Meijer2.   

Abstract

Entities:  

Keywords:  ADPKD; autosomal dominant polycystic kidney disease; body mass index; overweight

Mesh：

Year:  2021        PMID： 34117079      PMCID： PMC8216613          DOI： 10.2215/CJN.04150321

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   10.614


× No keyword cloud information.
  11 in total

1.  Association of sarcopenia with eGFR and misclassification of obesity in adults with CKD in the United States.

Authors:  Deep Sharma; Meredith Hawkins; Matthew K Abramowitz
Journal:  Clin J Am Soc Nephrol       Date:  2014-11-12       Impact factor: 8.237

2.  Plasma copeptin, a unifying factor behind the metabolic syndrome.

Authors:  Sofia Enhörning; Joachim Struck; Elisabet Wirfält; Bo Hedblad; Nils G Morgenthaler; Olle Melander
Journal:  J Clin Endocrinol Metab       Date:  2011-04-13       Impact factor: 5.958

3.  Effect of Lanreotide on Kidney Function in Patients With Autosomal Dominant Polycystic Kidney Disease: The DIPAK 1 Randomized Clinical Trial.

Authors:  Esther Meijer; Folkert W Visser; Rene M M van Aerts; Charles J Blijdorp; Niek F Casteleijn; Hedwig M A D'Agnolo; Shosha E I Dekker; Joost P H Drenth; Johan W de Fijter; Maatje D A van Gastel; Tom J Gevers; Marten A Lantinga; Monique Losekoot; A Lianne Messchendorp; Myrte K Neijenhuis; Michelle J Pena; Dorien J M Peters; Mahdi Salih; Darius Soonawala; Edwin M Spithoven; Jack F Wetzels; Robert Zietse; Ron T Gansevoort
Journal:  JAMA       Date:  2018-11-20       Impact factor: 56.272

4.  Body mass index and risk for end-stage renal disease.

Authors:  Chi-yuan Hsu; Charles E McCulloch; Carlos Iribarren; Jeanne Darbinian; Alan S Go
Journal:  Ann Intern Med       Date:  2006-01-03       Impact factor: 25.391

5.  Overweight and Obesity Are Predictors of Progression in Early Autosomal Dominant Polycystic Kidney Disease.

Authors:  Kristen L Nowak; Zhiying You; Berenice Gitomer; Godela Brosnahan; Vicente E Torres; Arlene B Chapman; Ronald D Perrone; Theodore I Steinman; Kaleab Z Abebe; Frederic F Rahbari-Oskoui; Alan S L Yu; Peter C Harris; Kyongtae T Bae; Marie Hogan; Dana Miskulin; Michel Chonchol
Journal:  J Am Soc Nephrol       Date:  2017-11-08       Impact factor: 10.121

6.  Tolvaptan in patients with autosomal dominant polycystic kidney disease.

Authors:  Vicente E Torres; Arlene B Chapman; Olivier Devuyst; Ron T Gansevoort; Jared J Grantham; Eiji Higashihara; Ronald D Perrone; Holly B Krasa; John Ouyang; Frank S Czerwiec
Journal:  N Engl J Med       Date:  2012-11-03       Impact factor: 91.245

7.  Food Restriction Ameliorates the Development of Polycystic Kidney Disease.

Authors:  Gina Warner; Kyaw Zaw Hein; Veronica Nin; Marika Edwards; Claudia C S Chini; Katharina Hopp; Peter C Harris; Vicente E Torres; Eduardo N Chini
Journal:  J Am Soc Nephrol       Date:  2015-11-04       Impact factor: 10.121

Review 8.  Metabolic Reprogramming in Autosomal Dominant Polycystic Kidney Disease: Evidence and Therapeutic Potential.

Authors:  Kristen L Nowak; Katharina Hopp
Journal:  Clin J Am Soc Nephrol       Date:  2020-02-21       Impact factor: 8.237

9.  Multicenter, open-label, extension trial to evaluate the long-term efficacy and safety of early versus delayed treatment with tolvaptan in autosomal dominant polycystic kidney disease: the TEMPO 4:4 Trial.

Authors:  Vicente E Torres; Arlene B Chapman; Olivier Devuyst; Ron T Gansevoort; Ronald D Perrone; Ann Dandurand; John Ouyang; Frank S Czerwiec; Jaime D Blais
Journal:  Nephrol Dial Transplant       Date:  2018-03-01       Impact factor: 5.992

10.  Overweight and Obesity and Progression of ADPKD.

Authors:  Kristen L Nowak; Cortney Steele; Berenice Gitomer; Wenchyi Wang; John Ouyang; Michel B Chonchol
Journal:  Clin J Am Soc Nephrol       Date:  2021-06-11       Impact factor: 10.614
View more
  1 in total

1.  Increased Body Fat and Organic Acid Anions Production Are Associated with Larger Kidney Size in ADPKD.

Authors:  Adriana Dos Santos Dutra; Fernanda Guedes Rodrigues; Daniel Ribeiro da Rocha; Larissa Collis Vendramini; Ana Cristina Carvalho de Matos; Ita Pfeferman Heilberg
Journal:  Medicina (Kaunas)       Date:  2022-01-19       Impact factor: 2.430
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.